Both Pfizer and Moderna’s COVID-19 vaccines are safe, and about 10 percent to 15 percent of recipients reported side effects that were “significantly noticeable.”
United Airlines carried the first mass air shipment of COVID-19 vaccines last week from Brussels to Chicago.
The FDA’s vaccine committee will meet Dec. 17 to discuss Moderna’s request for emergency approval of its COVID-19 vaccine.
Retail pharmacies and supermarkets are buying freezers, training staff and hiring more employees in preparation to administer COVID-19 vaccines when one is authorized.
AstraZeneca may conduct an additional global trial of its COVID-19 vaccine candidate after scrutiny from many scientists over its results.
Moderna filed for emergency use authorization of its COVID-19 vaccine candidate with the FDA Nov. 30.
Health system CEOs in North Carolina and Ohio told CNBC this week that they had discussed plans for vaccine distribution.
More articles on surgery centers:
10 recent ASC leadership moves
Virginia ASC takes infection prevention to new level — 3 insights
Surgery Partners goes all-in on cardiology — 5 quotes on its quarterly performance
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
